Work

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

Year: 1999

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: M A Morse, Y Deng, D Coleman, S Hull, E Kitrell-Fisher, S Nair, J Schlom, M E Ryback, H K Lyerly

Institution: Duke Medical Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources

Awards: GENERAL CLINICAL RESEARCH CENTER, IMMUNOTHERAPY WITH PEPTIDE PULSED DENDRITIC CELLS

OpenAlex ID: W2170055192

FWCI: 9.818

Cites: 34

Cited by: 300

Related to: 10